Solid Biosciences Inc.
NASDAQ:SLDB
7.86 (USD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 4.736 | 0 | 0 | 0 | 8.094 | 0 | 6.169 | 1.925 | 3.154 | 3.537 | 3.594 | 3.335 | 98.316 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.235 | 0.327 | 0.587 | 0.588 | 0.703 | 1.077 | 0.539 | 0.438 | 0.722 | 0.709 | 44.144 | 14.425 | 15.513 | 14.206 | 49.158 | 16.045 | 13.448 | 19.665 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -1.235 | -0.327 | 4.149 | -0.588 | -0.703 | -1.077 | 7.555 | -0.438 | 5.447 | 1.216 | -40.99 | -10.888 | -11.919 | -10.871 | 49.158 | -16.045 | -13.448 | -19.665 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.876 | 0 | 0 | 0 | 0.933 | 0 | 0.883 | 0.632 | -12.996 | -3.078 | -3.316 | -3.26 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 19.461 | 18.873 | 15.453 | 16.702 | 19.777 | 24.631 | 21.29 | 14.005 | 23.18 | 19.945 | 14.595 | 14.425 | 15.513 | 14.206 | 15.723 | 16.045 | 13.448 | 19.665 | 27.066 | 22.792 | 21.61 | 23.269 | 17.762 | 14.68 | 13.594 | 11.929 | 11.946 | 10.619 | 8.607 | 8.733 | 7.068 |
| General & Administrative Expenses
| 8.327 | 7.989 | 6.812 | 6.412 | 7.129 | 7.399 | 7.618 | 7.127 | 6.851 | 7.352 | 7.211 | 7.143 | 6.766 | 6.015 | 5.624 | 5.181 | 5.526 | 5.25 | 5.264 | 6.925 | 5.359 | 7.033 | 4.624 | 4.47 | 4.584 | 4.044 | 3.215 | 3.077 | 3.28 | 5.38 | 1.653 |
| Selling & Marketing Expenses
| 0 | -0.327 | -0.587 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.327 | 7.662 | 6.225 | 6.412 | 7.129 | 7.399 | 7.618 | 7.127 | 6.851 | 7.352 | 7.211 | 7.143 | 6.766 | 6.015 | 5.624 | 5.181 | 5.526 | 5.25 | 5.264 | 6.925 | 5.359 | 7.033 | 4.624 | 4.47 | 4.584 | 4.044 | 3.215 | 3.077 | 3.28 | 5.38 | 1.653 |
| Other Expenses
| 0 | 0.003 | 0.27 | 0.278 | 0.265 | 0.282 | -1.437 | 0.722 | 0.29 | 0.044 | -0.022 | 0.048 | 0.003 | -0.014 | 1.944 | -0.02 | 0 | 0.001 | 0.17 | 0.056 | 0.077 | 0.212 | 0.083 | 0.038 | 0.118 | 0.031 | 0.62 | 0.14 | 0.524 | 0.176 | 0.103 |
| Operating Expenses
| 27.788 | 26.535 | 21.678 | 23.114 | 26.906 | 32.03 | 28.908 | 21.132 | 30.031 | 27.297 | 21.806 | 21.568 | 22.279 | 20.221 | 21.347 | 21.226 | 18.974 | 24.915 | 32.33 | 29.717 | 26.969 | 30.302 | 22.386 | 19.15 | 18.178 | 15.973 | 15.161 | 13.696 | 11.887 | 14.113 | 8.721 |
| Operating Income
| -27.788 | -26.862 | -22.265 | -23.114 | -26.843 | -32.03 | -34.566 | -21.132 | -25.382 | -25.372 | -18.652 | -18.031 | -18.685 | -16.886 | -21.347 | -21.226 | -18.974 | -26.859 | -32.33 | -29.717 | -26.969 | -30.302 | -22.386 | -19.15 | -18.178 | -15.973 | -15.161 | -13.696 | -11.887 | -14.113 | -8.721 |
| Operating Income Ratio
| 0 | 0 | -4.701 | 0 | 0 | 0 | -4.271 | 0 | -4.114 | -13.18 | -5.914 | -5.098 | -5.199 | -5.063 | -0.217 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.716 | 2.559 | 1.929 | 2.134 | 0.328 | 1.96 | 19.415 | 0.722 | 0.29 | 0.044 | -0.022 | 0.048 | 0.003 | -0.014 | -0.016 | -0.02 | -0.013 | -1.943 | 0.17 | 0.056 | 0.077 | 0.212 | 0.083 | 0.038 | 0.118 | 0.031 | 0.62 | 0.14 | 0.524 | 0.176 | 0.103 |
| Income Before Tax
| -25.072 | -24.303 | -20.336 | -20.98 | -24.629 | -30.07 | -15.151 | -20.41 | -25.092 | -25.328 | -18.61 | -17.983 | -18.695 | -16.9 | -21.363 | -21.246 | -18.987 | -26.694 | -31.861 | -29.255 | -26.525 | -29.582 | -21.921 | -19.02 | -17.98 | -15.877 | -14.487 | -13.505 | -11.311 | -13.875 | -8.519 |
| Income Before Tax Ratio
| 0 | 0 | -4.294 | 0 | 0 | 0 | -1.872 | 0 | -4.067 | -13.157 | -5.9 | -5.084 | -5.202 | -5.067 | -0.217 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -1.235 | 0.284 | 4.56 | -0.588 | -2.012 | -1.96 | -19.749 | -0.722 | -0.29 | -0.044 | -0.064 | -0.001 | 0.013 | 0 | -0.001 | 0 | 0 | 1.78 | -0.299 | -0.406 | -0.367 | -0.508 | -0.382 | -0.092 | -0.08 | -0.065 | 1.06 | -0.051 | -0.052 | -1.122 | -0.862 |
| Net Income
| -25.072 | -24.303 | -20.336 | -20.98 | -24.629 | -28.11 | 4.598 | -19.688 | -24.802 | -25.284 | -18.61 | -17.983 | -18.695 | -16.9 | -21.363 | -21.246 | -18.987 | -26.694 | -31.861 | -29.255 | -26.525 | -29.582 | -21.921 | -19.02 | -17.98 | -15.877 | -14.487 | -13.505 | -11.311 | -12.815 | -7.756 |
| Net Income Ratio
| 0 | 0 | -4.294 | 0 | 0 | 0 | 0.568 | 0 | -4.02 | -13.135 | -5.9 | -5.084 | -5.202 | -5.067 | -0.217 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.61 | -0.64 | -1 | -1.05 | -1.25 | -1.44 | 0.24 | -2.61 | -3.3 | -3.37 | -2.53 | -2.4 | -2.55 | -2.84 | -6.64 | -6.6 | -5.91 | -8.33 | -9.96 | -10.1 | -11.42 | -12.76 | -9.49 | -8.26 | -7.83 | -8.11 | -11.3 | -10.53 | -8.82 | -9.99 | -6.05 |
| EPS Diluted
| -0.61 | -0.64 | -1 | -1.05 | -1.25 | -1.44 | 0.24 | -2.61 | -3.3 | -3.37 | -2.49 | -2.4 | -2.5 | -2.84 | -6.64 | -6.6 | -5.91 | -8.33 | -9.94 | -10.1 | -11.42 | -12.76 | -9.46 | -8.26 | -7.83 | -8.11 | -11.3 | -10.53 | -8.82 | -9.99 | -6.05 |
| EBITDA
| -27.788 | -26.535 | -21.678 | -23.114 | -26.266 | -30.953 | -40.947 | -20.694 | -21.62 | -24.663 | -17.892 | -17.28 | -17.966 | -16.152 | -20.552 | -20.46 | -17.64 | -21.945 | -31.524 | -28.953 | -26.311 | -29.706 | -21.905 | -18.605 | -17.865 | -15.746 | -14.938 | -13.586 | -11.823 | -14.062 | -8.687 |
| EBITDA Ratio
| 0 | 0 | -4.577 | 0 | 0 | 0 | -5.059 | 0 | -3.505 | -12.812 | -5.673 | -4.885 | -4.999 | -4.843 | -0.209 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |